The most common side effects seen in >20% of people with relapsed CLL taking ZYDELIG® (idelalisib) + Rituxan® (rituximab) and those taking placebo + Rituxan are shown in this table. These are not all the possible side effects of ZYDELIG.1
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You can also call 1-800-GILEAD-5 (1-800-445-3235).
Side effects may occur when you take ZYDELIG.
Some side effects may be managed if discussed early with your treatment teamLearn moreFind downloadable resources to help you
get and stay informed about your disease and treatmentLearn moreReference: